Some practical aspects of providing a diagnostic service for respiratory chain defects
- PMID: 12542905
- DOI: 10.1258/000456303321016114
Some practical aspects of providing a diagnostic service for respiratory chain defects
Abstract
The oxidative phosphorylation system (OXPHOS) is organized into five multi-protein complexes, comprising four complexes (I-IV) of the respiratory chain and ATP synthase (complex V). OXPHOS has a vital role in cellular energy metabolism and ATP production. Enzyme analysis of individual OXPHOS complexes in a skeletal muscle biopsy remains the mainstay of the diagnostic process for patients suspected of mitochondrial cytopathy. Practical guidelines are presented to provide optimal conditions for performance of laboratory investigations and a reliable diagnosis. A fresh muscle biopsy is preferable to a frozen muscle sample because the overall capacity of the OXPHOS system can be measured in a fresh biopsy. In about 25% of patients referred for muscle biopsy to our centre, reduced substrate oxidation rates and ATP+creatine phosphate production rates were found without any defect in complexes I-V and the pyruvate dehydrogenase complex. Investigation of frozen muscle biopsy alone may lead to false-negative diagnoses in many patients. In some patients, it is necessary to investigate fibroblasts for prospective diagnostic purposes. An exact diagnosis of respiratory chain defects is a prerequisite for rational therapy and genetic counselling. Provided guidelines for specimen collection are followed, there are now reliable methods for identifying respiratory chain defects.
Similar articles
-
Biochemical examination of fibroblasts in the diagnosis and research of oxidative phosphorylation (OXPHOS) defects.Mitochondrion. 2004 Sep;4(5-6):395-401. doi: 10.1016/j.mito.2004.07.005. Mitochondrion. 2004. PMID: 16120401
-
Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects.J Clin Pathol. 2009 Feb;62(2):172-6. doi: 10.1136/jcp.2008.061267. J Clin Pathol. 2009. PMID: 19181635
-
[Mitochondriopathies].Rev Neurol. 2003 Oct 16-31;37(8):775-9. Rev Neurol. 2003. PMID: 14593640 Review. Spanish.
-
Assaying ATP synthesis in cultured cells: a valuable tool for the diagnosis of patients with mitochondrial disorders.Biochem Biophys Res Commun. 2009 May 22;383(1):58-62. doi: 10.1016/j.bbrc.2009.03.121. Epub 2009 Mar 28. Biochem Biophys Res Commun. 2009. PMID: 19332025
-
Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation.Ann Clin Lab Sci. 2001 Jan;31(1):25-67. Ann Clin Lab Sci. 2001. PMID: 11314862 Review.
Cited by
-
Mutation in subdomain G' of mitochondrial elongation factor G1 is associated with combined OXPHOS deficiency in fibroblasts but not in muscle.Eur J Hum Genet. 2011 Mar;19(3):275-9. doi: 10.1038/ejhg.2010.208. Epub 2010 Dec 1. Eur J Hum Genet. 2011. PMID: 21119709 Free PMC article.
-
The in-depth evaluation of suspected mitochondrial disease.Mol Genet Metab. 2008 May;94(1):16-37. doi: 10.1016/j.ymgme.2007.11.018. Epub 2008 Feb 1. Mol Genet Metab. 2008. PMID: 18243024 Free PMC article. Review.
-
Mitochondrial hepatopathy: Respiratory chain disorders- 'breathing in and out of the liver'.World J Hepatol. 2021 Nov 27;13(11):1707-1726. doi: 10.4254/wjh.v13.i11.1707. World J Hepatol. 2021. PMID: 34904040 Free PMC article. Review.
-
NOA1 is an essential GTPase required for mitochondrial protein synthesis.Mol Biol Cell. 2011 Jan 1;22(1):1-11. doi: 10.1091/mbc.E10-07-0643. Epub 2010 Nov 30. Mol Biol Cell. 2011. PMID: 21118999 Free PMC article.
-
Mitochondrial ADP/ATP exchange inhibition: a novel off-target mechanism underlying ibipinabant-induced myotoxicity.Sci Rep. 2015 Sep 29;5:14533. doi: 10.1038/srep14533. Sci Rep. 2015. PMID: 26416158 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical